These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 33954824)

  • 1. Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa.
    Muhumuza R; Ssemata AS; Kakande A; Ahmed N; Atujuna M; Nomvuyo M; Bekker LG; Dietrich JJ; Tshabalala G; Hornschuh S; Maluadzi M; Chibanda-Stranix L; Nematadzira T; Weiss HA; Nash S; Fox J; Seeley J
    Arch Sex Behav; 2021 May; 50(4):1729-1742. PubMed ID: 33954824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe.
    Dietrich JJ; Ahmed N; Tshabalala G; Wu M; Mulaudzi M; Hornschuh S; Atujuna M; Muhumuza R; Ssemata AS; Stranix-Chibanda L; Nematadzira T; Bekker LG; Martinson N; Seeley J; Fox J
    PLoS One; 2023; 18(6):e0287627. PubMed ID: 37384792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial.
    Nash S; Dietrich J; Ssemata AS; Herrera C; O'Hagan K; Else L; Chiodi F; Kelly C; Shattock R; Chirenje M; Lebina L; Khoo S; Bekker LG; Weiss HA; Gray C; Stranix-Chibanda L; Kaleebu P; Seeley J; Martinson N; Fox J;
    Trials; 2020 Oct; 21(1):900. PubMed ID: 33121503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
    BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms of post-traumatic stress and associations with sexual behaviour and PrEP preferences among young people in South Africa, Uganda and Zimbabwe.
    Webb EL; Dietrich JJ; Ssemata AS; Nematadzira TG; Hornschuh S; Kakande A; Tshabalala G; Muhumuza R; Mutonyi G; Atujuna M; Bere T; Bekker LG; Abas MA; Weiss HA; Seeley J; Stranix-Chibanda L; Fox J;
    BMC Infect Dis; 2022 May; 22(1):466. PubMed ID: 35578175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
    Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
    PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe.
    Dietrich JJ; Ahmed N; Webb EL; Tshabalala G; Hornschuh S; Mulaudzi M; Atujuna M; Stranix-Chibanda L; Nematadzira T; Ssemata AS; Muhumuza R; Seeley J; Bekker LG; Weiss HA; Martinson N; Fox J;
    J Int AIDS Soc; 2022 Aug; 25(8):e25975. PubMed ID: 36002910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study.
    Cholo FA; Dada S; Martin CE; Mullick S
    J Int AIDS Soc; 2024 May; 27(5):e26249. PubMed ID: 38695102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative exploration to understand barriers and facilitators to daily oral PrEP uptake and sustained adherence among HIV-negative women planning for or with pregnancy in rural Southwestern Uganda.
    Atukunda EC; Owembabazi M; Pratt MC; Psaros C; Muyindike W; Chitneni P; Bwana MB; Bangsberg D; Haberer JE; Marrazzo J; Matthews LT
    J Int AIDS Soc; 2022 Mar; 25(3):e25894. PubMed ID: 35324081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study.
    Camlin CS; Koss CA; Getahun M; Owino L; Itiakorit H; Akatukwasa C; Maeri I; Bakanoma R; Onyango A; Atwine F; Ayieko J; Kabami J; Mwangwa F; Atukunda M; Owaraganise A; Kwarisiima D; Sang N; Bukusi EA; Kamya MR; Petersen ML; Cohen CR; Charlebois ED; Havlir DV
    AIDS Behav; 2020 Jul; 24(7):2149-2162. PubMed ID: 31955361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
    Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
    Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescent-Centered HIV Prevention: Perspectives on Acceptability of Oral Antiretroviral Pre-exposure Prophylaxis for Adolescents in a Global Priority Setting.
    Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
    Arch Sex Behav; 2021 Oct; 50(7):2921-2931. PubMed ID: 34561792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and facilitators to uptake and persistence on prep among key populations in Southern Province, Zambia: a thematic analysis.
    Stoebenau K; Muchanga G; Ahmad SS; Bwalya C; Mwale M; Toussaint S; Maambo C; Peters CJ; Baumhart C; Mwango LK; Lavoie MC; Claassen CW
    BMC Public Health; 2024 Jun; 24(1):1617. PubMed ID: 38886691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
    Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
    BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "I'm doing this test so I can benefit from PrEP": exploring HIV testing barriers/facilitators and implementation of pre-exposure prophylaxis among South African adolescents.
    Yoshioka E; Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
    Afr J AIDS Res; 2020 Jul; 19(2):101-108. PubMed ID: 32326813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries.
    Kakande A; Ssemata AS; Muhumuza R; Atujuna M; Abaasa A; Ndekezi D; Tshabalala G; Nematadzira T; Hornschuh S; Nomvuyo M; Ahmed N; Maluadzi M; Anne Weiss H; Webb E; Stranix-Chibanda L; Janine Dietrich J; Seeley J; Fox J
    PLoS One; 2023; 18(10):e0285132. PubMed ID: 37812644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative Assessment of Barriers and Facilitators of PrEP Use Before and After Rollout of a PrEP Program for Priority Populations in South-central Uganda.
    Ddaaki W; Strömdahl S; Yeh PT; Rosen JG; Jackson J; Nakyanjo N; Kagaayi J; Kigozi G; Nakigozi G; Grabowski MK; Chang LW; Reynolds SJ; Nalugoda F; Ekström AM; Kennedy CE
    AIDS Behav; 2021 Nov; 25(11):3547-3562. PubMed ID: 34240317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
    Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
    Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.